AIP
RLYB icon

Ameritas Investment Partners’s Rallybio RLYB Stock Holding History

Ameritas Investment Partners’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-316
Closed -$4.67K – 3217
2024
Q1 		$4.67K Hold
316
– – ﹤0.01% 2957
2023
Q4 		$6.04K Hold
316
– – ﹤0.01% 2943
2023
Q3 		$8.51K Hold
316
– – ﹤0.01% 2879
2023
Q2 		$14.3K Buy
316
+140
+80% +$6.86K ﹤0.01% 2742
2023
Q1 		$8.05K Hold
176
– – ﹤0.01% 2783
2022
Q4 		$11.3K Hold
176
– – ﹤0.01% 2776
2022
Q3 		$20K Hold
176
– – ﹤0.01% 2527
2022
Q2 		$10K Buy
176
+107
+155% +$8.04K ﹤0.01% 2838
2022
Q1 		$4K Hold
69
– – ﹤0.01% 3002
2021
Q4 		$5K Hold
69
– – ﹤0.01% 3043
2021
Q3 		$10K Buy
+69
New +$8.09K ﹤0.01% 2939

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameritas Investment Partners's RLYB Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 316 shares — an estimated $4.67K sold.

Ameritas Investment Partners first reported a position in RLYB in Q3 2021 and held it in 11 quarters. The position peaked at $20K in Q3 2022. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 316 Rallybio shares in Q2 2024, an estimated $4.67K.
  • Ameritas Investment Partners first reported a position in Rallybio in Q3 2021 and held it in 11 quarters.
  • Ameritas Investment Partners's Rallybio position peaked at $20K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.